Year |
Citation |
Score |
2024 |
Budhu S, Kim K, Yip W, La Rosa S, Jebiwott S, Cai L, Holland A, Thomas J, Preise D, Somma A, Gordon B, Scherz A, Wolchok JD, Erinjeri J, Merghoub T, et al. Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model. Frontiers in Oncology. 14: 1405486. PMID 38957315 DOI: 10.3389/fonc.2024.1405486 |
0.394 |
|
2021 |
Modai J, Kovalyonok A, Scherz A, Preise D, Avda Y, Shpunt I, Sasson K, Jaber M, Peretz Y, Croock R, Shilo Y, Ikher S, Lindner U, Leibovici D. Single Instillation of Hypertonic Saline Immediately Following Transurethral Resection of Bladder Tumor for Recurrence Prevention -A Phase I Study. Bladder Cancer (Amsterdam, Netherlands). 7: 187-192. PMID 38994536 DOI: 10.3233/BLC-200328 |
0.348 |
|
2021 |
Sjoberg HT, Philippou Y, Magnussen AL, Tullis IDC, Bridges E, Chatrian A, Lefebvre J, Tam KH, Murphy EA, Rittscher J, Preise D, Agemy L, Yechezkel T, Smart SC, Kinchesh P, et al. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer. British Journal of Cancer. PMID 34155340 DOI: 10.1038/s41416-021-01450-6 |
0.444 |
|
2018 |
Goldschmidt R, Koudinova N, Sasson K, Preise D, Agemy L, Mohan V, Bochner F, Sagi I, Neeman M, Scherz A. Vascular targeted photodynamic therapy for pancreatic ductal adenocarcinoma: A pre-clinical success Annals of Oncology. 29: iii21. DOI: 10.1093/Annonc/Mdy047.045 |
0.45 |
|
2017 |
Uzana R, Preise D, Agemy L, Elmualem R, Kelsen D, Gerdes H, Coleman J, Murray K, Belkin V, Sasson K, Yehezkel T, Salomon Y, Scherz A. A novel vascular targeted photodynamic therapy (VTP) in orthotopic rat model for the treatment of esophageal cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 28: iii13-iii14. PMID 32135740 DOI: 10.1093/Annonc/Mdx261.002 |
0.663 |
|
2016 |
Uzana R, Preise D, Agemy L, Elmoalem R, Belkin V, Sasson K, Yechezkel T, Salomon Y, Scherz AJ. Palliative treatment of obstructive esophageal cancer by vascular targeted photodynamic therapy (VTP): Preclinical study in orthotopic rat model. Journal of Clinical Oncology. 34: 59-59. DOI: 10.1200/Jco.2016.34.4_Suppl.59 |
0.71 |
|
2016 |
Preise D, Kudinova N, Lindner U, Sasson K, Uzana R, Coleman J, Salomon Y, Scherz A. Abstract B012: Immunomodulated VTP enables cure of metastatic prostate and breast cancers in animal models Cancer Immunology Research. 4. DOI: 10.1158/2326-6074.Cricimteatiaacr15-B012 |
0.691 |
|
2016 |
Lindner U, Preise D, Kudinova N, Agaronov A, Salomon Y, Coleman J, Leibovichi D. 38 Preventing occurrence of metastatic disease in rats with locally advanced prostate cancer by immunomodulation and vascular targeted therapy European Urology Supplements. 15: e38. DOI: 10.1016/S1569-9056(16)60040-4 |
0.632 |
|
2016 |
Lindner U, Preise D, Kudinova N, Agarounov A, Salomon Y, Coleman JA, Leibovici D, Scherz A. MP62-07 NEOADJUVANT IMMUNOMODULATION COMBINED WITH VASCULAR TARGETED THERAPY PREVENTS METASTASES AND IMPROVES SURVIVAL IN RATS WITH LOCALLY ADVANCED PROSTATE CANCER. Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.915 |
0.644 |
|
2015 |
Uzana R, Preise D, Agemy L, Elmoalem R, Brandis A, Belkin V, Salomon Y, Scherz A. The treatment of esophageal cancer by vascular-targeted photodynamic therapy (VTP) using orthotopic rat model. Journal of Clinical Oncology. 33: 91-91. DOI: 10.1200/Jco.2015.33.3_Suppl.91 |
0.706 |
|
2011 |
Preise D, Scherz A, Salomon Y. Antitumor immunity promoted by vascular occluding therapy: lessons from vascular-targeted photodynamic therapy (VTP). Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 10: 681-8. PMID 21258718 DOI: 10.1039/C0Pp00315H |
0.712 |
|
2009 |
Preise D, Oren R, Glinert I, Kalchenko V, Jung S, Scherz A, Salomon Y. Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity. Cancer Immunology, Immunotherapy : Cii. 58: 71-84. PMID 18488222 DOI: 10.1007/S00262-008-0527-0 |
0.69 |
|
2008 |
Fleshker S, Preise D, Kalchenko V, Scherz A, Salomon Y. Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate. Photochemistry and Photobiology. 84: 1231-7. PMID 18399928 DOI: 10.1111/J.1751-1097.2008.00340.X |
0.64 |
|
2003 |
Preise D, Mazor O, Koudinova N, Liscovitch M, Scherz A, Salomon Y. Bypass of tumor drug resistance by antivascular therapy. Neoplasia (New York, N.Y.). 5: 475-80. PMID 14965440 DOI: 10.1016/S1476-5586(03)80031-3 |
0.66 |
|
Show low-probability matches. |